BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2016
View Archived Issues
AstraZeneca reflects on highlights of fourth quarter 2015
Read More
City of Hope develops technology to create cell-permeable antibodies
Read More
OncoMed gives update on ALPINE and PINNACLE studies of tarextumab
Read More
PharmaMar's phase III lurbinectedin study to continue
Read More
Aurinia Pharmaceuticals completes preliminary analysis of AURION study
Read More
Innov17 patents retinoid-related orphan receptor ligands
Read More
Cisen Pharmaceutical and Medshine Discovery reveal compounds to treat tuberculosis
Read More
FDA places full clinical hold on pacritinib
Read More
New animal model created for the investigation of glanders
Read More
PDS Biotechnology and NCI to codevelop novel cancer immunotherapies
Read More
Adaptimmune's NY-ESO T-cell therapy earns FDA breakthrough therapy designation
Read More
Sanofi presents milestones of fourth quarter 2015
Read More
Study of amifampridine phosphate in MuSK-antibody positive myasthenia gravis begins
Read More
Novel fibrinogen mutations are associated with congenital hypofibrinogenemia
Read More
VBI and GSK enter vaccine research collaboration
Read More
Phase I data support progression of Immune Design's immuno-oncology candidates
Read More
Cellceutix plans SPA request for phase III study of brilacidin in ABSSSI
Read More
Target for interfering with MYC oncogene activity identified
Read More
Merck & Co. files BLA for house dust mite SLIT tablet
Read More
Scientists identify unusual mutations in moderate hemophilia B patients
Read More
FDA recommends approval of Celltrion's infliximab biosimilar, Epirus advances own biosimilar
Read More
BioCryst reports phase II/III results for liquid capsule formulation of avoralstat
Read More
Nymox announces results from phase II prostate cancer study
Read More
EMA creates Zika virus task force, HemispheRx announces its approach
Read More